EPISODE · Jun 29, 2026 · 19 MIN
The Missing Pathway in Cholesterol Biology: How Ral GTPases Control LDL Receptor Destruction
from The Deep Dive Lab: Unraveling Materials Science · host Son Hoang
For decades, cholesterol research has centered on LDL receptor production and the PCSK9 pathway. A landmark 2026 study published in Nature reveals an entirely new layer of regulation: a cholesterol-sensitive RAS–Ral signaling pathway that actively determines whether LDL receptors are recycled or destroyed.In this episode, we unpack the molecular mechanism linking membrane cholesterol sensing, RalA/RalB activation, SNX17-mediated receptor recycling, lysosomal trafficking, and Cathepsin A (CTSA)-dependent degradation. We also examine why this pathway operates independently of both transcriptional regulation and PCSK9, potentially explaining why current lipid-lowering therapies reach a therapeutic ceiling.Finally, we explore human genetic evidence from GWAS and discuss how targeting Ral or CTSA may represent a new class of therapies for dyslipidemia and cardiovascular disease.Reference:Feng X. et al. (2026). Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover. Nature.#Nature #LDLR #RalGTPase #CTSA #Metabolism #CardiovascularResearch #MolecularBiology #LipidMetabolism #SciencePodcast 🧬
What this episode covers
For decades, cholesterol research has centered on LDL receptor production and the PCSK9 pathway. A landmark 2026 study published in Nature reveals an entirely new layer of regulation: a cholesterol-sensitive RAS–Ral signaling pathway that actively determines whether LDL receptors are recycled or destroyed.In this episode, we unpack the molecular mechanism linking membrane cholesterol sensing, RalA/RalB activation, SNX17-mediated receptor recycling, lysosomal trafficking, and Cathepsin A (CTSA)-dependent degradation. We also examine why this pathway operates independently of both transcriptional regulation and PCSK9, potentially explaining why current lipid-lowering therapies reach a therapeutic ceiling.Finally, we explore human genetic evidence from GWAS and discuss how targeting Ral or CTSA may represent a new class of therapies for dyslipidemia and cardiovascular disease.Reference:Feng X. et al. (2026). Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover. Nature.#Nature #LDLR #RalGTPase #CTSA #Metabolism #CardiovascularResearch #MolecularBiology #LipidMetabolism #SciencePodcast 🧬
NOW PLAYING
The Missing Pathway in Cholesterol Biology: How Ral GTPases Control LDL Receptor Destruction
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.